Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB26FX1KG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $97,500
Award facts
- Contract value 100% obligated
- $97,499.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at approximately $97.5K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, awarded on October 23, 2025, represents a direct purchase without set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal pharmaceutical procurement. The contract is scheduled for ultimate completion by November 14, 2025, with performance occurring at the vendor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract with the Defense Logistics Agency, a $30.3 billion acquisition strategy supporting Department of Defense pharmaceutical supply needs. The PPV-G GEN V program establishes multiple regional prime vendor contractors authorized to provide firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables to military healthcare facilities worldwide. DMS Pharmaceutical Group's single-award IDC, valued at $500M with a completion date of December 31, 2036, positions the company as a critical pharmaceutical supplier for DoD healthcare operations globally, with this Stelara delivery order exemplifying the routine medical supply acquisitions executed through the broader prime vendor framework.
Quick answers
Who was awarded contract SPE2DB26FX1KG?
SPE2DB26FX1KG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FX1KG worth?
The government has obligated $97,500 on SPE2DB26FX1KG.
Is contract SPE2DB26FX1KG an order under another contract?
Yes. SPE2DB26FX1KG is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB26FX1KG competed?
The extent of competition for SPE2DB26FX1KG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award